Literature DB >> 40688

A survey of psychotropic drug prescriptions in an oncology population.

L R Derogatis, M Feldstein, G Morrow, A Schmale, M Schmitt, C Gates, B Murawski, J Holland, D Penman, N Melisaratos, A J Enelow, L M Adler.   

Abstract

The present study examined the prescription practices concerning psychotropic drugs in 5 major oncology centers over a 6 month period. During the survey period 1579 patients were admitted to the collaborating institutions, and 51% of them were prescribed at least one psychotropic medication. Hypnotics were the most frequently prescribed drugs, accounting for 48% of total prescriptions, followed by anti-psychotics at 26% and anti-anxiety agents at 25%. Anti-depressant drugs accounted for only 1% of psychotropic prescriptions. Analysis of prescription rationales revealed that 44% of the psychotropic prescriptions were written for sleep, while 25% were given for nausea and vomiting; approximately 17% were attributed to psychological distress, and 12% were associated with diagnostic medical procedures. The overall rate of prescription was approximately 2 psychotropic drugs per patient per admission, with only 2% of prescriptions resulting in chart-documented side effects. At the level of individual compounds, 3 distinct drugs accounted for 72% of total prescriptions--flurazepam (33%), prochlorperazine (21%), and diazepam (17%).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40688     DOI: 10.1002/1097-0142(197911)44:5<1919::aid-cncr2820440555>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Sleep aid use during and following breast cancer adjuvant chemotherapy.

Authors:  Tiffany A Moore; Ann M Berger; Paul Dizona
Journal:  Psychooncology       Date:  2011-03       Impact factor: 3.894

Review 3.  Psychopharmacology in psycho-oncology.

Authors:  Rosangela Caruso; Luigi Grassi; Maria Giulia Nanni; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 4.  The relationship between fatigue and sleep in cancer patients: a review.

Authors:  S Ancoli-Israel; P J Moore; V Jones
Journal:  Eur J Cancer Care (Engl)       Date:  2001-12       Impact factor: 2.520

5.  Anxiety in terminally ill cancer patients.

Authors:  Elissa Kolva; Barry Rosenfeld; Hayley Pessin; William Breitbart; Robert Brescia
Journal:  J Pain Symptom Manage       Date:  2011-05-12       Impact factor: 3.612

6.  Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life.

Authors:  O Paltiel; A Marzec-Boguslawska; V Soskolne; S Massalha; M Avitzour; R Pfeffer; N Cherny; T Peretz
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

7.  Sleep dysfunction in patients with cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

8.  Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure.

Authors:  Chong Guan Ng; Ellen Dijkstra; Hugo Smeets; Marco P M Boks; Niek J de Wit
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

9.  Psychosomatic Aspects of Gynecologic Oncology: Present Status and Future Directions.

Authors:  Barbara L Andersen; Barrie Anderson
Journal:  J Psychosom Obstet Gynaecol       Date:  1986-12-01       Impact factor: 2.949

10.  Radiation Therapy and Psychological Distress in Gynecologic Oncology Patients: Outcomes and Recommendations for Enhancing Adjustment.

Authors:  Jennifer A Karlsson; Barbara L Andersen
Journal:  J Psychosom Obstet Gynaecol       Date:  1986       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.